Ozer, H <br/><br/>
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma.  [electronic resource] 

 -  Investigational new drugs  1987 
 - S27-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0167-6997 
<br/><br/><label>Standard No.: </label>10.1007/BF00207260  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anemia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Clinical Trials as Topic<br/>Cyclophosphamide--adverse effects<br/>Female<br/>Humans<br/>Interferon Type I--adverse effects<br/>Lymphoma, Non-Hodgkin--therapy<br/>Male<br/>Middle Aged<br/>Thrombocytopenia--chemically induced